Unknown

Dataset Information

0

Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems.


ABSTRACT:

Background

Amphetamine analogs with a 3,4-methylenedioxy ring-substitution are among the most popular illicit drugs of abuse, exerting stimulant and entactogenic effects. Enzymatic N-demethylation or opening of the 3,4-methylenedioxy ring via O-demethylenation gives rise to metabolites that may be pharmacologically active. Indeed, previous studies in rats show that specific metabolites of 3,4-methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxymethcathinone (methylone) and 3,4-methylenedioxypyrovalerone (MDPV) can interact with monoaminergic systems.

Aim

Interactions of metabolites of MDMA, methylone and MDPV with human monoaminergic systems were assessed.

Methods

The ability of parent drugs and their metabolites to inhibit uptake of tritiated norepinephrine, dopamine and serotonin (5-HT) was assessed in human embryonic kidney 293 cells transfected with human monoamine transporters. Binding affinities and functional activity at monoamine transporters and various receptor subtypes were also determined.

Results

MDMA and methylone displayed greater potency to inhibit norepinephrine uptake as compared to their effects on dopamine and 5-HT uptake. N-demethylation of MDMA failed to alter uptake inhibition profiles, whereas N-demethylation of methylone decreased overall transporter inhibition potencies. O-demethylenation of MDMA, methylone and MDPV resulted in catechol metabolites that maintained norepinephrine and dopamine uptake inhibition potencies, but markedly reduced activity at 5-HT uptake. O-methylation of the catechol metabolites significantly decreased norepinephrine uptake inhibition, resulting in metabolites lacking significant stimulant properties.

Conclusions

Several metabolites of MDMA, methylone and MDPV interact with human transporters and receptors at pharmacologically relevant concentrations. In particular, N-demethylated metabolites of MDMA and methylone circulate in unconjugated form and could contribute to the in vivo activity of the parent compounds in human users.

SUBMITTER: Luethi D 

PROVIDER: S-EPMC8269116 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9981643 | biostudies-literature
| S-EPMC9736016 | biostudies-literature
| S-EPMC8753974 | biostudies-literature
2024-01-18 | GSE253280 | GEO
| S-EPMC4443958 | biostudies-literature
| S-EPMC8389614 | biostudies-literature
| S-EPMC5837893 | biostudies-literature
| S-EPMC5809783 | biostudies-other
| S-EPMC4983252 | biostudies-other
| S-EPMC8011213 | biostudies-literature